Interesting Nearmap can sustain valuation of $650M Enterprise Value with total revenue of $54M in FY18 and ARR of $67M, suggesting multiple of 9.7 x ARR(or ACV). Nearmap is still loss-making like Catapult, losing $11M in FY18 (Catapult had loss of $17M in FY18 as comparison).
Catapult had revenue of $76M in FY18 and ARR of $53.4M and targeting to reach at least $64M by FY19. Even at ARR of $53.4M last year and using 9.7 multiple, it should be trading at $488M Enterprise Valuation today, which suggests a share price of $2.88 today considering Catapult has cash of $32M.
Significantly undervalued in my opinion considering that the nature of the recurring revenues for these 2 companies are quite similar and both operating in the tech space.
But no matter what I say...it will still stay below $1.10..because the market is inefficient..
- Forums
- ASX - By Stock
- Valuation Comparison
Interesting Nearmap can sustain valuation of $650M Enterprise...
-
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.42 |
Change
0.030(0.88%) |
Mkt cap ! $638.2M |
Open | High | Low | Value | Volume |
$3.41 | $3.51 | $3.34 | $5.142M | 1.509M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $3.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.47 | 6413 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.980 |
1 | 4986 | 0.970 |
1 | 1036 | 0.965 |
2 | 32659 | 0.960 |
2 | 41512 | 0.940 |
Price($) | Vol. | No. |
---|---|---|
0.990 | 1 | 1 |
1.000 | 42518 | 3 |
1.010 | 10000 | 1 |
1.020 | 25000 | 1 |
1.040 | 18507 | 4 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
CAT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online